MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-β

Jielu Hao1,2, Qiang Lou2,3, Qingqing Wei2

  • 1From the Department of Nephrology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.

Insights

Cisplatin chemotherapy causes kidney damage. This study reveals miR-375, induced by P53 and NF-κB, promotes this nephrotoxicity by suppressing protective HNF-1β. Understanding this pathway aids in developing kidney-protective strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Nephrology

Background:

  • Cisplatin chemotherapy is vital for cancer treatment but causes significant kidney toxicity (nephrotoxicity).
  • The exact mechanisms behind cisplatin-induced nephrotoxicity are not fully understood, hindering the development of effective protective therapies.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various cellular processes, including drug-induced toxicity.

Purpose of the Study:

  • To investigate the role of specific microRNAs (miRNAs) in the development of cisplatin-induced nephrotoxicity.
  • To identify key molecular players and pathways involved in cisplatin's damaging effects on kidney cells.
  • To explore potential therapeutic targets for mitigating cisplatin-induced kidney damage.

Main Methods:

  • Conditional knockout of the miRNA-generating enzyme Dicer in mouse kidney proximal tubular cells.
  • Microarray analysis to profile miRNA expression in kidney cortical tissues after cisplatin treatment.
  • In vitro experiments involving inhibition of specific miRNAs (miR-375) and key signaling molecules (P53, NF-κB) in renal tubular cells.
  • Western blot analysis to assess protein levels of downstream targets (HNF-1β).

Main Results:

  • Overall miRNA depletion did not alter cisplatin-induced nephrotoxicity.
  • Microarray analysis identified 47 up-regulated and 20 down-regulated miRNAs in cisplatin-treated kidneys.
  • miR-375 expression was significantly increased in cisplatin-treated renal cells and promoted apoptosis.
  • P53 and NF-κB pathways were found to induce miR-375 expression.
  • Hepatocyte nuclear factor 1 homeobox B (HNF-1β) was identified as a direct downstream target of miR-375, and its expression protected against cisplatin-induced apoptosis.

Conclusions:

  • Cisplatin exposure triggers P53 and NF-κB to up-regulate miR-375.
  • miR-375 promotes cisplatin-induced renal tubular cell apoptosis by suppressing the protective factor HNF-1β.
  • These findings elucidate a novel molecular mechanism of cisplatin nephrotoxicity and highlight miR-375 and HNF-1β as potential targets for renoprotective strategies.